Zurich Cantonal Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3,469,549
Closed -$86.4M – 3251
2025
Q4
$86.4M Buy
+3,469,549
New +$87.5M 0.19% 98

Other funds holding PFE

Zurich Cantonal Bank's PFE Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $3.12M and leaving 3,686,223 shares worth $88.8M. The position accounts for 0.17% of the portfolio, ranked #99.

Zurich Cantonal Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $175M in Q4 2022. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Zurich Cantonal Bank held 3,686,223 shares of Pfizer worth $88.8M as of Q2 2026.
  • Zurich Cantonal Bank sold 119,319 Pfizer shares in Q2 2026, an estimated $3.12M.
  • Pfizer made up 0.17% of Zurich Cantonal Bank's portfolio in Q2 2026, its #99 holding.
  • Zurich Cantonal Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Zurich Cantonal Bank's Pfizer position peaked at $175M in Q4 2022.
  • 2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.